Pharma marketed antidepressants to children after hiding the risk of suicide and aggression revealed by clinical trials

‘A BMJ press release reported, “Children and adolescents have a doubled risk of aggression and suicide when taking one of the five most commonly prescribed antidepressants,” according to a study published in The BMJ on January 28, 2016.

Selective serotonin reuptake inhibitors (SSRIs) and serotonin–norepinephrine reuptake inhibitors (SNRIs) are the most commonly prescribed antidepressants, the release notes.

Researchers from the Nordic Cochrane Centre in Denmark carried out a systematic review and meta-analysis of 68 clinical study reports of 70 trials involving 18,526 patients to examine use of antidepressants and associated serious harms, including “deaths, suicidal thoughts and attempts as well as aggression and akathisia, a form of restlessness that may increase suicide and violence.”‘

Read more: Pharma marketed antidepressants to children after hiding the risk of suicide and aggression revealed by clinical trials

The post Pharma marketed antidepressants to children after hiding the risk of suicide and aggression revealed by clinical trials appeared first on David Icke.